NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

Authors

Eleftherios P. Mamounas

NSABP/NRG Oncology, and UF Cancer Center at Orlando Health, Orlando, FL

Eleftherios P. Mamounas , Hanna Bandos , Julia R. White , Thomas B. Julian , Atif J. Khan , Simona Flora Shaitelman , Mylin Ann Torres , Frank Vicini , Patricia A. Ganz , Susan Ann McCloskey , Soonmyung Paik , Nilendu Gupta , X. Allen Li , Dominic J. DiCostanzo , Walter John Curran Jr., Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2018 ASCO Annual Meeting

bookmark_border

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

First Author: Eleftherios P. Mamounas

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

First Author: Eleftherios P. Mamounas

insert_chart_outlined

Poster

2015 ASCO Annual Meeting

bookmark_border

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

First Author: Eleftherios P. Mamounas

insert_chart_outlined

Poster

2013 Breast Cancer Symposium

bookmark_border

Outcomes of sentinel lymph node–positive breast cancer patients treated with mastectomy without axillary therapy.

First Author: Elizabeth FitzSullivan